4//SEC Filing
Pacala Mark L 4
Accession 0001799191-24-000035
CIK 0001799191other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:52 PM ET
Size
6.9 KB
Accession
0001799191-24-000035
Insider Transaction Report
Form 4
Pacala Mark L
Director
Transactions
- Other
Common stock
2024-11-12−30,372→ 84,409 total - Other
Common stock
2024-11-12−20,248→ 114,781 total
Footnotes (2)
- [F1]Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
- [F2]Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001321250
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:52 PM ET
- Size
- 6.9 KB